[Hyperkinetic syndrome (author's transl)]. 1976

H C Steinhausen

This review reports on symptoms, prevalence, etiopathogenesis, prognosis and course, therapy as well as on theory of the hyperkinetic syndrome.

UI MeSH Term Description Entries
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011613 Psychotherapy A generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication. Psychotherapies
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006948 Hyperkinesis Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders. Hyperactivity, Motor,Hyperkinesia,Hyperkinesia, Generalized,Hyperkinetic Movements,Generalized Hyperkinesia,Generalized Hyperkinesias,Hyperkinesias, Generalized,Hyperkinetic Movement,Motor Hyperactivity,Movement, Hyperkinetic,Movements, Hyperkinetic
D000662 Amphetamines Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant

Related Publications

H C Steinhausen
January 1979, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
H C Steinhausen
September 1978, Lijecnicki vjesnik,
H C Steinhausen
January 1976, Annales medico-psychologiques,
H C Steinhausen
September 1974, Monatsschrift fur Kinderheilkunde,
H C Steinhausen
January 1970, Acta paediatrica Belgica,
H C Steinhausen
August 1974, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
H C Steinhausen
January 1975, Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie,
H C Steinhausen
December 1974, Ceskoslovenska gynekologie,
H C Steinhausen
March 1980, Nihon Jibiinkoka Gakkai kaiho,
H C Steinhausen
March 1975, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!